By Lucy Parkinson, VP of Investor Research, LSN
Cross-border investment is a growing theme in early stage life science, with investors forming global syndicates and moving new technologies toward market in multiple regions simultaneously to maximize their returns. However, this creates significant complexities at the legal level, both from an investment perspective and also a regulatory one, not to mention creating concerns about IP protection. Entrepreneurs are often in need of expert advice on these complexities that arise from acting globally.
RESI Shanghai Agenda
In conjunction with RESI Shanghai, our sponsors McDermott, Will & Emery are holding the 3rd China Life Science And Health Care Outbound Legal Symposium at the Ritz Carlton Pudong on November 12th. This full day track of content from legal experts, focused on cross-border activities and investment topics, will be open to all RESI Shanghai attendees. Additionally, McDermott, Will & Emery will present a half-day of expert legal content at RESI Taipei on November 14th.
Next Phase Newsletter 
Leave a comment